Accelerate Diagnostics Stock Market Value
| AXDX Stock | USD 0.93 0.02 2.11% |
| Symbol | Accelerate |
Accelerate Diagnostics Price To Book Ratio
Is Accelerate Diagnostics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Accelerate Diagnostics. If investors know Accelerate will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Accelerate Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.94) | Revenue Per Share 0.966 | Quarterly Revenue Growth 0.019 | Return On Assets (0.70) |
The market value of Accelerate Diagnostics is measured differently than its book value, which is the value of Accelerate that is recorded on the company's balance sheet. Investors also form their own opinion of Accelerate Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Accelerate Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Accelerate Diagnostics' market value can be influenced by many factors that don't directly affect Accelerate Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Accelerate Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Accelerate Diagnostics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Accelerate Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Accelerate Diagnostics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Accelerate Diagnostics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Accelerate Diagnostics.
| 02/02/2023 |
| 04/27/2024 |
If you would invest 0.00 in Accelerate Diagnostics on February 2, 2023 and sell it all today you would earn a total of 0.00 from holding Accelerate Diagnostics or generate 0.0% return on investment in Accelerate Diagnostics over 450 days. Accelerate Diagnostics is related to or competes with Orthofix Medical, Glaukos Corp, Integer Holdings, CONMED, LivaNova PLC, IRhythm Technologies, and Zimmer Biomet. Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infection... More
Accelerate Diagnostics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Accelerate Diagnostics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Accelerate Diagnostics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.08) | |||
| Maximum Drawdown | 27.87 | |||
| Value At Risk | (9.89) | |||
| Potential Upside | 9.52 |
Accelerate Diagnostics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Accelerate Diagnostics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Accelerate Diagnostics' standard deviation. In reality, there are many statistical measures that can use Accelerate Diagnostics historical prices to predict the future Accelerate Diagnostics' volatility.| Risk Adjusted Performance | (0.03) | |||
| Jensen Alpha | (0.46) | |||
| Total Risk Alpha | (1.08) | |||
| Treynor Ratio | (0.32) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Accelerate Diagnostics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Accelerate Diagnostics Backtested Returns
Accelerate Diagnostics secures Sharpe Ratio (or Efficiency) of -0.0766, which signifies that the company had a -0.0766% return per unit of standard deviation over the last 3 months. Accelerate Diagnostics exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Accelerate Diagnostics' mean deviation of 4.4, and Risk Adjusted Performance of (0.03) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 1.15, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Accelerate Diagnostics will likely underperform. Accelerate Diagnostics has an expected return of -0.43%. Please make sure to confirm Accelerate Diagnostics information ratio, as well as the relationship between the kurtosis and period momentum indicator , to decide if Accelerate Diagnostics performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.45 |
Modest reverse predictability
Accelerate Diagnostics has modest reverse predictability. Overlapping area represents the amount of predictability between Accelerate Diagnostics time series from 2nd of February 2023 to 15th of September 2023 and 15th of September 2023 to 27th of April 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Accelerate Diagnostics price movement. The serial correlation of -0.45 indicates that just about 45.0% of current Accelerate Diagnostics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.45 | |
| Spearman Rank Test | -0.33 | |
| Residual Average | 0.0 | |
| Price Variance | 4.58 |
Accelerate Diagnostics lagged returns against current returns
Autocorrelation, which is Accelerate Diagnostics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Accelerate Diagnostics' stock expected returns. We can calculate the autocorrelation of Accelerate Diagnostics returns to help us make a trade decision. For example, suppose you find that Accelerate Diagnostics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Accelerate Diagnostics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Accelerate Diagnostics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Accelerate Diagnostics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Accelerate Diagnostics stock over time.
Current vs Lagged Prices |
| Timeline |
Accelerate Diagnostics Lagged Returns
When evaluating Accelerate Diagnostics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Accelerate Diagnostics stock have on its future price. Accelerate Diagnostics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Accelerate Diagnostics autocorrelation shows the relationship between Accelerate Diagnostics stock current value and its past values and can show if there is a momentum factor associated with investing in Accelerate Diagnostics.
Regressed Prices |
| Timeline |
Pair Trading with Accelerate Diagnostics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Accelerate Diagnostics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Accelerate Diagnostics will appreciate offsetting losses from the drop in the long position's value.Moving against Accelerate Stock
| 0.76 | HCWB | HCW Biologics | PairCorr |
| 0.76 | KRYS | Krystal Biotech Financial Report 13th of May 2024 | PairCorr |
| 0.7 | ELEV | Elevation Oncology Earnings Call This Week | PairCorr |
| 0.62 | FHTX | Foghorn TherapeuticsInc Financial Report 13th of May 2024 | PairCorr |
| 0.59 | IOVA | Iovance Biotherapeutics Financial Report 14th of May 2024 | PairCorr |
The ability to find closely correlated positions to Accelerate Diagnostics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Accelerate Diagnostics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Accelerate Diagnostics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Accelerate Diagnostics to buy it.
The correlation of Accelerate Diagnostics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Accelerate Diagnostics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Accelerate Diagnostics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Accelerate Diagnostics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Accelerate Diagnostics Correlation, Accelerate Diagnostics Volatility and Accelerate Diagnostics Alpha and Beta module to complement your research on Accelerate Diagnostics. For more information on how to buy Accelerate Stock please use our How to Invest in Accelerate Diagnostics guide.Note that the Accelerate Diagnostics information on this page should be used as a complementary analysis to other Accelerate Diagnostics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Complementary Tools for Accelerate Stock analysis
When running Accelerate Diagnostics' price analysis, check to measure Accelerate Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Accelerate Diagnostics is operating at the current time. Most of Accelerate Diagnostics' value examination focuses on studying past and present price action to predict the probability of Accelerate Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Accelerate Diagnostics' price. Additionally, you may evaluate how the addition of Accelerate Diagnostics to your portfolios can decrease your overall portfolio volatility.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |
Accelerate Diagnostics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.